Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Excellent outcomes among people starting HIV therapy at high CD4 counts in Uganda

People in Uganda starting antiretroviral therapy (ART) with higher CD4 counts can achieve excellent outcomes, investigators report in the online edition of AIDS. Asymptomatic adults who started therapy

Published
08 August 2014
By
Michael Carter
Non-adherence to medication threatens Cambodia’s zero AIDS deaths target

The Cambodian Government has committed to reaching zero AIDS-related deaths by 2020. But the number of deaths among people who are living with HIV continues to rise, despite the fact that antiretroviral treatment is more widely available. One reason for this is because some people living with HIV are missing follow-up hospital appointments and failing to adhere to antiretroviral treatment.

Published
07 August 2014
From
Key Correspondents
South African women living with HIV subtype C experience rapid CD4 cell loss

A third of women living with HIV subtype C have a fall in their CD4 count to below 350 cells/mm3 within a year of seroconversion, investigators

Published
05 August 2014
By
Michael Carter
HIV drugs 'boost South African life expectancy'

South Africans are living on average up to 61.2 years compared to 52.2 years nearly 10 years ago, mainly thanks to life-saving Aids drugs, a government report says.

Published
04 August 2014
From
BBC
Theraclone Sciences cuts HIV antibodies deal with Gilead

Theraclone Sciences Inc. of Seattle said it's made a deal with Gilead Sciences Inc. that will allow the Foster City-based biotech giant to develop and commercialize Theraclone's neutralizing HIV-antibodies for therapeutic applications in HIV.

Published
31 July 2014
From
San Francisco Business Times (blog)
Mothers starting antiretrovirals in Malawi lost from care more frequently, revealing weaknesses in Option B+ implementation

Although Malawi’s policy of offering lifelong antiretroviral therapy (ART) to women living with HIV who are pregnant or breastfeeding resulted in a sevenfold increase in women

Published
30 July 2014
By
Carole Leach-Lemens
Switching from first-line ART with suppressed viral load linked to treatment failure

People who switch away from their initial antiretroviral therapy (ART) regimen when their viral load is undetectable may have a higher likelihood of subsequent virological failure, researchers reported

Published
29 July 2014
By
Liz Highleyman
Of guidelines, targets and resources: the documents that defined the 2014 International AIDS Conference

If there was a phrase that defined the 20th International AIDS Conference (AIDS 2014), one that surfaced in every few presentations and kept turning up in documents,

Published
26 July 2014
By
Gus Cairns
Efavirenz use not linked to neurocognitive impairment

People who use antiretroviral regimens containing efavirenz (Sustiva or Stocrin, also in the Atripla coformulation) were not at higher risk for impaired neurocognitive function, either overall or when looking

Published
25 July 2014
By
Liz Highleyman
Men Who Have Sex With Men Getting Treatment Sooner

Long-term trends indicate that European men who have sex with men are seeking treatment for HIV at earlier stages of their disease, researchers reported here.

Published
25 July 2014
From
MedPage Today

Filter by country